Rahim N, Sarfraz M, Bello A, Naqvi S
AAPS PharmSciTech. 2025; 26(1):38.
PMID: 39821536
DOI: 10.1208/s12249-024-03026-y.
Kassianides X, Bhandari S
BMC Nephrol. 2024; 25(1):54.
PMID: 38347520
PMC: 10860218.
DOI: 10.1186/s12882-023-03440-7.
Chang S, Huang W, Chapron A, Quinones A, Wang J, Isoherranen N
Pharm Res. 2023; 40(11):2597-2606.
PMID: 37704895
PMC: 11901350.
DOI: 10.1007/s11095-023-03594-x.
Kikuchi H, Chou C, Yang C, Chen L, Jung H, Park E
Nat Commun. 2023; 14(1):3481.
PMID: 37328470
PMC: 10276015.
DOI: 10.1038/s41467-023-38958-9.
Bogdanova E, Sadykov A, Ivanova G, Zubina I, Beresneva O, Semenova N
Int J Mol Sci. 2023; 24(8).
PMID: 37108433
PMC: 10138582.
DOI: 10.3390/ijms24087270.
Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic.
Hu L, Napoletano A, Provenzano M, Garofalo C, Bini C, Comai G
Int J Mol Sci. 2022; 23(20).
PMID: 36293076
PMC: 9603742.
DOI: 10.3390/ijms232012223.
Drug-Dosing Adjustment in Dogs and Cats with Chronic Kidney Disease.
De Santis F, Boari A, Dondi F, Crisi P
Animals (Basel). 2022; 12(3).
PMID: 35158584
PMC: 8833495.
DOI: 10.3390/ani12030262.
Age-Related Change in Hepatic Clearance Inferred from Multiple Population Pharmacokinetic Studies: Comparison with Renal Clearance and Their Associations with Organ Weight and Blood Flow.
Soejima K, Sato H, Hisaka A
Clin Pharmacokinet. 2021; 61(2):295-305.
PMID: 34514537
DOI: 10.1007/s40262-021-01069-z.
A generic crystallopathic model for chronic kidney disease progression.
Moe O
J Clin Invest. 2021; 131(16).
PMID: 34396990
PMC: 8363275.
DOI: 10.1172/JCI151858.
There is Only One Valid Definition of Clearance: Critical Examination of Clearance Concepts Reveals the Potential for Errors in Clinical Drug Dosing Decisions.
Benet L, Sodhi J, Makrygiorgos G, Mesbah A
AAPS J. 2021; 23(3):67.
PMID: 33973074
PMC: 8110503.
DOI: 10.1208/s12248-021-00591-z.
Population pharmacokinetics and dosing optimization of metformin in Chinese patients with type 2 diabetes mellitus.
Li L, Guan Z, Li R, Zhao W, Hao G, Yan Y
Medicine (Baltimore). 2020; 99(46):e23212.
PMID: 33181704
PMC: 7668473.
DOI: 10.1097/MD.0000000000023212.
Physiologically-Based Pharmacokinetic Modelling of Creatinine-Drug Interactions in the Chronic Kidney Disease Population.
Takita H, Scotcher D, Chinnadurai R, Kalra P, Galetin A
CPT Pharmacometrics Syst Pharmacol. 2020; 9(12):695-706.
PMID: 33049120
PMC: 7762809.
DOI: 10.1002/psp4.12566.
Novel Mechanistic PBPK Model to Predict Renal Clearance in Varying Stages of CKD by Incorporating Tubular Adaptation and Dynamic Passive Reabsorption.
Huang W, Isoherranen N
CPT Pharmacometrics Syst Pharmacol. 2020; 9(10):571-583.
PMID: 32977369
PMC: 7577018.
DOI: 10.1002/psp4.12553.
A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Drug-Drug-Gene Interaction Model of Metformin and Cimetidine in Healthy Adults and Renally Impaired Individuals.
Hanke N, Turk D, Selzer D, Ishiguro N, Ebner T, Wiebe S
Clin Pharmacokinet. 2020; 59(11):1419-1431.
PMID: 32449077
PMC: 7658088.
DOI: 10.1007/s40262-020-00896-w.
The number of nephrons in different glomerular diseases.
Viggiano D, Nigro M, Sessa F, Vignolini G, Campi R, Serni S
PeerJ. 2019; 7:e7640.
PMID: 31534861
PMC: 6731770.
DOI: 10.7717/peerj.7640.
Pharmacokinetics in children with chronic kidney disease.
Schijvens A, de Wildt S, Schreuder M
Pediatr Nephrol. 2019; 35(7):1153-1172.
PMID: 31375913
PMC: 7248054.
DOI: 10.1007/s00467-019-04304-9.
Clinical aspects of the phosphate transporters NaPi-IIa and NaPi-IIb: mutations and disease associations.
Lederer E, Wagner C
Pflugers Arch. 2018; 471(1):137-148.
PMID: 30542787
DOI: 10.1007/s00424-018-2246-5.
The intact nephron hypothesis as a model for renal drug handling.
Pradhan S, Duffull S, Walker R, Wright D
Eur J Clin Pharmacol. 2018; 75(2):147-156.
PMID: 30298363
DOI: 10.1007/s00228-018-2572-8.
Does Secretory Clearance Follow Glomerular Filtration Rate in Chronic Kidney Diseases? Reconsidering the Intact Nephron Hypothesis.
Chapron A, Shen D, Kestenbaum B, Robinson-Cohen C, Himmelfarb J, Yeung C
Clin Transl Sci. 2017; 10(5):395-403.
PMID: 28675584
PMC: 5593164.
DOI: 10.1111/cts.12481.
A general empirical model for renal drug handling in pharmacokinetic analyses.
Wright D, Duffull S
Br J Clin Pharmacol. 2017; 83(9):1869-1872.
PMID: 28419522
PMC: 5555866.
DOI: 10.1111/bcp.13306.
